prescription drug pricing

House brief on Trump’s ‘disdain’ kicks off what could be messy two weeks
Cases in D.C., New Orleans showcase tussle between branches of government

House Oversight and Reform chairman Elijah Cummings is leading a House effort to subpoena President Donald Trump’s financial records. (Bill Clark/CQ Roll Call file photo)

The House told a federal appeals court Monday that President Donald Trump has “disdain” for congressional oversight ahead of action next week on the House’s efforts to subpoena his financial records from accounting firm Mazars USA. The brief sets the stage for what could be a messy couple of weeks legally on fights between Congress and the administration. 

“Mr. Trump’s disdain for the constitutionally based role of Congress in carrying out oversight of the Executive Branch, and for the specific investigations of the Oversight Committee at issue here, is not a basis for this Court to reverse the district court’s holding that the subpoena is valid and enforceable,” the brief stated.

Odd bedfellows share concerns over Pelosi drug plan
Conservatives and progressives wary of drug price arbitration, but for different reasons

Speaker of the House Nancy Pelosi, D-Calif., is developing a drug price plan that focuses on drug price arbitration. (Photo By Bill Clark/CQ Roll Call)

Grassley sees chance to pass infrastructure, drug price legislation
CQ Budget Podcast, Episode 106

Sen. Charles Grassley, R-Iowa, speaks with reporters as he arrives for the Senate Republicans' lunch in the Capitol. (Photo By Bill Clark/CQ Roll Call)

After HR 1 vote, Democrats ready to move quickly on other top 10 bills
Pelosi has been steadily rolling out bills HR 1 through 10 to keep priorities advancing

Speaker Nancy Pelosi says Democrats are following through on their campaign promises with legislation. She’s designated bills HR 1 through HR 10 to reflect those top priorities. (Tom Williams/CQ Roll Call)

Updated 12:03 p.m. | House Democrats were in high spirits Friday after they passed the top item on their policy agenda — a package of voting, campaign finance and ethics overhauls dubbed HR 1 — but they’re not going to stop to celebrate for too long.

The new Democratic majority has been quickly, but steadily and deliberately, rolling out legislation to fulfill their 2018 midterm campaign promises and reintroducing bills that languished during the past eight years when Republicans controlled the House.